Co-Diagnostics Inc. (CODX)
NASDAQ · Healthcare
Co-Diagnostics Inc. Operating Income 2017–2025
Co-Diagnostics Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Co-Diagnostics Inc. operating income for the quarter ending March 31, 2026 was -9.2 M, a 7.68% increase year-over-year.
- Co-Diagnostics Inc. operating income for the twelve months ending March 31, 2026 was -32.8 M, a 11.53% decrease year-over-year.
- Co-Diagnostics Inc. annual operating income for 2025 was -50.2 M, a 25.16% increase from 2024.
- Co-Diagnostics Inc. annual operating income for 2024 was -40.1 M, a 6.15% decrease from 2023.
- Co-Diagnostics Inc. annual operating income for 2023 was -42.7 M, a 58.29% increase from 2022.
- Co-Diagnostics Inc. annual operating income for 2022 was -27.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Co-Diagnostics Inc. Operating Income — FAQ
Co-Diagnostics Inc. (CODX) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Co-Diagnostics Inc.'s operating income?
Co-Diagnostics Inc. (CODX) reported operating income of -$50M for fiscal 2025.
Where can I see CODX's operating income history?
The chart and table above show Co-Diagnostics Inc.'s operating income by year and by quarter, including the growth rate.